Elixirgen Therapeutics announced it raised $3.6 Million in an initial filing from an offering of $3.6 Million
Elixirgen Therapeutics announced it raised $3.6 Million in an initial filing from an offering of $3.6 Million
04/09/25, 3:28 PM
Location
baltimoreMoney raised
$3.6 million
Industry
biotechnology
Round Type
seed
Company Info
Location
855 n. wolfe st.
baltimore, maryland, united states
Additional Info
Elixirgen Therapeutics is a biotechnology company advancing its controllable self-replicating RNA technology to develop therapies for a broad spectrum of diseases, including rare diseases, aging-related disorders, and cancer. Elixirgen Therapeutics is located in the Science + Technology Park at Johns Hopkins in Baltimore.